Cogent Biosciences, Inc. (COGT)
34.44
-0.12
(-0.36%)
USD |
NASDAQ |
Sep 03, 10:42
Cogent Biosciences Net Income (Annual) : -328.94M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -328.94M |
| December 31, 2024 | -255.86M |
| December 31, 2023 | -192.41M |
| December 31, 2022 | -140.24M |
| December 31, 2021 | -72.27M |
| December 31, 2020 | -74.81M |
| Date | Value |
|---|---|
| December 31, 2019 | -31.83M |
| December 31, 2018 | -34.55M |
| December 31, 2017 | -25.56M |
| December 31, 2016 | -18.19M |
| December 31, 2015 | -6.635M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Apogee Therapeutics, Inc. | -255.84M |
| Erasca, Inc. | -124.55M |
| Moderna, Inc. | -2.822B |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |